The influence of partners on successful lifestyle modification in patients with coronary artery disease

Autor: Verweij, Lotte ^{a, b, 1, ⁎}, Jørstad, Harald T. ^{a, 1}, Minneboo, Madelon ^{a, 1}, ter Riet, Gerben ^{a, b, 1}, Peters, Ron J.G. ^{a, 1}, Scholte op Reimer, Wilma J.M. ^{a, c, 1}, Snaterse, Marjolein ^{a, b, 1}

Publikováno v: In International Journal of Cardiology 1 June 2021 332:195-201

Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients

Autor: Simona Radice, Maria Fazio, Marjorie Argollo, Marie Socha, Damien Loeuille, Ailsa Hart, Elena Vegni, Gionata Fiorino, Carmelo Carlo-Stella, Laurent Peyrin-Biroulet, Anthony Lopez, Silvio Danese, Stefanos Bonovas, Antonio Costanzo, Marien González-Lorenzo, Carlo Selmi, Fernando Magro, Daniela Gilardi, Lieven Pouillon

Publikováno v: Alimentary Pharmacology & Therapeutics (Suppl)
Alimentary Pharmacology & Therapeutics (Suppl), 2019, 49 (9), pp.1181-1187. ⟨10.1111/apt.15223⟩

Background The nocebo effect is a negative effect of a pharmacological or nonpharmacological medical treatment that is induced by patients' expectations, and that is unrelated to the physiological action of the treatment. The nocebo effect can negati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0a954b75dec0a8b7cfebb2c2910b2bd
https://doi.org/10.1111/apt.15223

Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study

Autor: Nekkab, Narimane, Lana, Raquel, Lacerda, Marcus, Obadia, Thomas, Siqueira, André, Monteiro, Wuelton, Villela, Daniel, Mueller, Ivo, White, Michael

Publikováno v: PLoS Medicine
PLoS Medicine, 2021, 18 (4), pp.e1003535. ⟨10.1371/journal.pmed.1003535⟩
PLoS Medicine, Vol 18, Iss 4, p e1003535 (2021)

Background Despite recent intensification of control measures, Plasmodium vivax poses a major challenge for malaria elimination efforts. Liver-stage hypnozoite parasites that cause relapsing infections can be cleared with primaquine; however, poor tr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a2f73f0417a243e9a128d5ba695665bb
https://hal-pasteur.archives-ouvertes.fr/pasteur-03617084

High-intensity lipid-lowering regimens in patients with stable coronary artery disease: the intriguing question of all-cause mortality

Autor: Nicolas Danchin, Tabassome Simon

Publikováno v: European Heart Journal-Cardiovascular Pharmacotherapy
European Heart Journal-Cardiovascular Pharmacotherapy, Oxford Academy, 2020, 6 (5), pp.328-330. ⟨10.1093/ehjcvp/pvz049⟩
European Heart Journal-Cardiovascular Pharmacotherapy, Oxford Academy, 2020, 6 (4), pp.328-330. ⟨10.1093/ehjcvp/pvz049⟩
European Heart Journal — Cardiovascular Pharmacotherapy

International audience; Full secondary prevention medication regimen is often under-prescribed after acute myocardial infarction.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e4d70c11d85bdc0174d28780b7298a8
https://hal.archives-ouvertes.fr/hal-03028540

Comment permettre aux personnes souffrant de troubles des conduites alimentaires un accès plus précoce aux soins ?

Autor: KALINDJIAN, Nina

Publikováno v: Médecine humaine et pathologie. 2018

Introduction: an earlier detection of eating disorders (ED) would improve their outcome and decrease the morbidity and mortality, prevent the risk of evolution towards chronicity and physical, mental and social complications. The aim of this present

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2592::4cf43734f43773555faf34738624a587
https://dumas.ccsd.cnrs.fr/dumas-02292852